Loading...
Eyenovia, Inc.
EYEN•NASDAQ
Healthcare
Biotechnology
$10.38
$-0.50(-4.60%)
Eyenovia, Inc. (EYEN) Financial Performance & Statements
Review Eyenovia, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
1414.02%
↑ 1414.02%
Operating Income Growth
-91.83%
↓ 91.83%
Net Income Growth
-82.75%
↓ 82.75%
Operating Cash Flow Growth
-26.36%
↓ 26.36%
Operating Margin
-61885.23%
↓ 61885.23%
Gross Margin
-5891.32%
↓ 5891.32%
Net Profit Margin
-63194.11%
↓ 63194.11%
ROE
789.91%
↑ 789.91%
ROIC
455.25%
↑ 455.25%
Eyenovia, Inc. (EYEN) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Eyenovia, Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $28093.00 | $1625.00 | $22625.00 | $4993.00 |
| Cost of Revenue | $3.10M | $132522.00 | $784071.00 | $336453.00 |
| Gross Profit | -$3.07M | -$130897.00 | -$761446.00 | -$331460.00 |
| Gross Profit Ratio | -$109.39 | -$80.55 | -$33.66 | -$66.38 |
| R&D Expenses | $1.96M | $3.47M | $4.60M | $4.10M |
| SG&A Expenses | $3.21M | $3.73M | $3.76M | $3.84M |
| Operating Expenses | $14.88M | $7.20M | $8.06M | $7.94M |
| Total Costs & Expenses | $17.55M | $7.33M | $11.71M | $8.27M |
| Interest Income | $23220.00 | $44999.00 | $64866.00 | $120939.00 |
| Interest Expense | $529663.00 | $602109.00 | $674000.00 | $678658.00 |
| Depreciation & Amortization | $297844.00 | $287481.00 | $295396.00 | $331460.00 |
| EBITDA | -$19.21M | -$7.04M | -$10.09M | -$10.02M |
| EBITDA Ratio | -$683.83 | -$4335.04 | -$445.79 | -$2006.63 |
| Operating Income | -$19.45M | -$7.33M | -$11.69M | -$8.27M |
| Operating Income Ratio | -$692.38 | -$4511.96 | -$516.61 | -$1655.68 |
| Other Income/Expenses (Net) | -$503650.00 | -$555926.00 | $634645.00 | -$655277.00 |
| Income Before Tax | -$19.95M | -$7.89M | -$11.05M | -$10.92M |
| Income Before Tax Ratio | -$710.31 | -$4854.06 | -$488.56 | -$2187.48 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $288184.00 |
| Net Income | -$19.95M | -$7.89M | -$11.05M | -$10.92M |
| Net Income Ratio | -$710.31 | -$4854.06 | -$488.56 | -$2187.48 |
| EPS | -$22.95 | -$8.80 | -$0.21 | -$0.23 |
| Diluted EPS | -$22.95 | -$8.80 | -$0.21 | -$0.23 |
| Weighted Avg Shares Outstanding | $1.14M | $869479.00 | $796826.00 | $699102.00 |
| Weighted Avg Shares Outstanding (Diluted) | $1.14M | $869479.00 | $796826.00 | $699102.00 |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan